Lipid News

A surprising modification lowers the lipid binding affinity of a membrane trafficking protein

Jefferson Knight Colin T. Shearn Cisloynny Beauchamp–Pérez
By Jefferson Knight, Colin T. Shearn and Cisloynny Beauchamp–Pérez
Aug. 24, 2021

Proteins undergo nonenzymatic modification by reacting with various molecules. For example, cysteine residues react with the alkylating reagent iodoacetamide, and amino groups react with certain carbonyl compounds including succinimidyl esters.

Nonspecific protein modifications in human tissues also are associated with a number of diseases; for example, most of the long-term consequences of diabetes arise from a damaging series of reactions involving blood glucose (an aldehyde) forming covalent bonds to amino groups on various proteins.

Physicians calculate average blood glucose concentrations in diabetic patients by measuring the levels of the glycated protein hemoglobin A1C, a modified form of the red blood cell protein with glucose attached to the N-terminal amino group of the beta-chain. Because such nonenzymatic reactions are typically irreversible, they result in damaged proteins that can lose function and must be removed via proteolytic degradation, a cell’s normal process of breaking down proteins and recycling amino acids.

In a lab, when reactions occur on foreign proteins during bacterial expression, researchers need to design a purification strategy that removes the modified protein. Many modifications do not show up in sodium dodecyl sulfate polyacrylamide gel electrophoresis analysis and thus are easily overlooked.

In a recent study, we identified an endogenous protein modification occurring on a cluster of lysine residues that are central to lipid binding properties in the vesicle trafficking protein granuphilin, or Slp-4. This protein binds reversibly to plasma membranes via a conserved region called a C2 domain, which binds membranes independently of calcium via a large positively charged surface that interacts with negatively charged lipids. At the center of this surface is a cluster of lysines that has a high affinity for the plasma membrane lipid phosphatidylinositol-(4,5)-bisphosphate, or PIP2. We also found that two of these conserved lysines are susceptible to modification by the endogenous bacterial compound phosphogluconolactone, an intermediate in the pentose phosphate pathway. Not surprisingly, the modified protein binds much less strongly to PIP2 lipids than the unmodified protein.

Researchers previously have reported phosphogluconoylation of bacterially expressed proteins but only as a modification on an N-terminal His-tag, never on an internal lysine sidechain. The modified protein manifested as an early-eluting peak during cation-exchange purification, and we identified the site of modification using mass spectrometry following trypsin digestion.

Jefferson Knight
The C2A domain of granuphilin binds strongly to plasma membranes containing PIP2 via a conserved
lysine cluster (red circle) embedded in a large electropositive surface (blue oval) containing many basic
residues (blue sticks). A single exposed hydrophobic residue (gray sticks) also contributes to membrane affinity.

Researchers also already knew that certain PIP2-binding C2 domains must be purified via cation exchange in order to obtain reproducible results. Our results suggest that the purpose of this step is not only to remove nucleic acid contaminants but also to separate out this endogenous bacterial modification, which can be a significant percentage of the total protein.

Why is this observation important to lipid biochemistry? Some of the most reactive carbonyl compounds in mammalian cells are aldehydes derived from polyunsaturated fatty acids, or PUFAs. These compounds are downstream products that arise from reaction of PUFAs with reactive oxygen species such as peroxide and superoxide, which become more abundant during oxidative stress and inflammation. PUFAs are especially abundant as acyl chains in phosphoinositide lipids such as PIP2.

Therefore, our observation of reactivity in this PIP2-binding lysine cluster raises several questions: How reactive is this lysine cluster toward endogenous lipid aldehydes in mammalian cells? Does lysine modification affect membrane trafficking? Are there other proteins with lysine clusters that possess similar reactivity?

A serendipitous observation of protein modification during bacterial expression has opened the door to questions at the heart of protein chemistry and membrane biology.

Jefferson Knight
Jefferson Knight

Jefferson Knight is an associate professor and director of the biochemistry Bachelor of Science program in the chemistry department at the University of Colorado Denver.

Colin T. Shearn
Colin T. Shearn

Colin T. Shearn is a research assistant professor in the pediatrics department at the University of Colorado Anschutz Medical Campus.

Cisloynny Beauchamp–Pérez
Cisloynny Beauchamp–Pérez

Cisloynny Beauchamp–Pérez is a Masters of Science student in Jefferson Knight’s lab at the University of Colorado Denver.

Related articles

Tour de flippase
Todd R. Graham
Lipid regulation of mitochondria
Yoshihiro Adachi, Miho Iijima & Hiromi Sesaki
At the interface
Lina M. Obeid & Michael J. Pulkoski-Gross

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Finding the right research path

Finding the right research path

Sept. 16, 2021

Karen Bornfeldt, an associate editor for the Journal of Lipid Research, investigates how diabetes increases cardiovascular disease risk.

From the journals: JBC
Journal News

From the journals: JBC

Sept. 15, 2021

Antibody interactions that change cytotoxicity. An atlas for macrophage activation. Anti–Zika virus natural products. Read about papers on these and other topics.

Noboru Sueoka (1929 – 2021)

Noboru Sueoka (1929 – 2021)

Sept. 13, 2021

Sueoka made widely known contributions to our understanding of DNA replication. Indeed, he coined the term “origin of replication.”

From CRISPR to glowing proteins to optogenetics

From CRISPR to glowing proteins to optogenetics

Sept. 12, 2021

Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.

Lobsters hold the secret of a long, cancer-free life in their genes

Lobsters hold the secret of a long, cancer-free life in their genes

Sept. 11, 2021

More than a mere delicacy, the humble lobster could teach us a lot about healthy aging.

Personal chemistry: Proteomics tackles privacy concerns

Personal chemistry: Proteomics tackles privacy concerns

Sept. 9, 2021

Sharing raw data is an important norm for the proteomics community. But as clinical studies become more detailed, researchers may need to clamp down to protect patient privacy.